These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34591613)

  • 1. Interpretation of cancer mutations using a multiscale map of protein systems.
    Zheng F; Kelly MR; Ramms DJ; Heintschel ML; Tao K; Tutuncuoglu B; Lee JJ; Ono K; Foussard H; Chen M; Herrington KA; Silva E; Liu SN; Chen J; Churas C; Wilson N; Kratz A; Pillich RT; Patel DN; Park J; Kuenzi B; Yu MK; Licon K; Pratt D; Kreisberg JF; Kim M; Swaney DL; Nan X; Fraley SI; Gutkind JS; Krogan NJ; Ideker T
    Science; 2021 Oct; 374(6563):eabf3067. PubMed ID: 34591613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive assessment of cancer missense mutation clustering in protein structures.
    Kamburov A; Lawrence MS; Polak P; Leshchiner I; Lage K; Golub TR; Lander ES; Getz G
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5486-95. PubMed ID: 26392535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Principles of Gene Fusion Mediated Rewiring of Protein Interaction Networks in Cancer.
    Latysheva NS; Oates ME; Maddox L; Flock T; Gough J; Buljan M; Weatheritt RJ; Babu MM
    Mol Cell; 2016 Aug; 63(4):579-592. PubMed ID: 27540857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of synthetic lethal pairs in biological systems through network information centrality.
    Kranthi T; Rao SB; Manimaran P
    Mol Biosyst; 2013 Aug; 9(8):2163-7. PubMed ID: 23728082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
    Ruffalo M; Koyutürk M; Sharan R
    PLoS Comput Biol; 2015 Dec; 11(12):e1004595. PubMed ID: 26683094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces.
    Engin HB; Kreisberg JF; Carter H
    PLoS One; 2016; 11(4):e0152929. PubMed ID: 27043210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-structure-guided discovery of functional mutations across 19 cancer types.
    Niu B; Scott AD; Sengupta S; Bailey MH; Batra P; Ning J; Wyczalkowski MA; Liang WW; Zhang Q; McLellan MD; Sun SQ; Tripathi P; Lou C; Ye K; Mashl RJ; Wallis J; Wendl MC; Chen F; Ding L
    Nat Genet; 2016 Aug; 48(8):827-37. PubMed ID: 27294619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovering distinct functional modules of specific cancer types using protein-protein interaction networks.
    Shen R; Wang X; Guda C
    Biomed Res Int; 2015; 2015():146365. PubMed ID: 26495282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying mutation specific cancer pathways using a structurally resolved protein interaction network.
    Engin HB; Hofree M; Carter H
    Pac Symp Biocomput; 2015; 20():84-95. PubMed ID: 25592571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protein interaction landscape of breast cancer.
    Kim M; Park J; Bouhaddou M; Kim K; Rojc A; Modak M; Soucheray M; McGregor MJ; O'Leary P; Wolf D; Stevenson E; Foo TK; Mitchell D; Herrington KA; Muñoz DP; Tutuncuoglu B; Chen KH; Zheng F; Kreisberg JF; Diolaiti ME; Gordan JD; Coppé JP; Swaney DL; Xia B; van 't Veer L; Ashworth A; Ideker T; Krogan NJ
    Science; 2021 Oct; 374(6563):eabf3066. PubMed ID: 34591612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational landscape of phosphorylation signaling in cancer.
    Reimand J; Wagih O; Bader GD
    Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancerouspdomains: comprehensive analysis of cancer type-specific recurrent somatic mutations in proteins and domains.
    Hashemi S; Nowzari Dalini A; Jalali A; Banaei-Moghaddam AM; Razaghi-Moghadam Z
    BMC Bioinformatics; 2017 Aug; 18(1):370. PubMed ID: 28814324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracting significant sample-specific cancer mutations using their protein interactions.
    Badea L
    Pac Symp Biocomput; 2014; ():15-26. PubMed ID: 24297530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes.
    Galka-Marciniak P; Urbanek-Trzeciak MO; Nawrocka PM; Kozlowski P
    Nucleic Acids Res; 2021 Jan; 49(2):601-620. PubMed ID: 33406242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probabilistic model of the human protein-protein interaction network.
    Rhodes DR; Tomlins SA; Varambally S; Mahavisno V; Barrette T; Kalyana-Sundaram S; Ghosh D; Pandey A; Chinnaiyan AM
    Nat Biotechnol; 2005 Aug; 23(8):951-9. PubMed ID: 16082366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINA 3.0: mining cancer interactome.
    Du Y; Cai M; Xing X; Ji J; Yang E; Wu J
    Nucleic Acids Res; 2021 Jan; 49(D1):D1351-D1357. PubMed ID: 33231689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of quantitative proteomics data and interaction networks: Identification of dysregulated cellular functions during cancer progression.
    Zanzoni A; Brun C
    Methods; 2016 Jan; 93():103-9. PubMed ID: 26386316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
    Porta-Pardo E; Garcia-Alonso L; Hrabe T; Dopazo J; Godzik A
    PLoS Comput Biol; 2015 Oct; 11(10):e1004518. PubMed ID: 26485003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.